ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Douglas J. Mathisen
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mathisen, D. J.
Right arrow Articles by Peabody, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mathisen, D. J.
Right arrow Articles by Peabody, J.

Ann Thorac Surg 1979;27:295-299
© 1979 The Society of Thoracic Surgeons

Articles

The Role of Thoracotomy in the Management of Pulmonary Metastases from Malignant Melanoma

Douglas J. Mathisen, M.D.*, M. Wayne Flye, M.D., Joseph Peabody, M.D.

Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD

* Address reprint requests to Dr. Mathisen, Surgery Branch, NCI, Building 10, Room 10N116, National Institutes of Health, Bethesda, MD 20014

Thirty-three patients over a 21-year period underwent thoracotomy for resection of suspected pulmonary metastases from malignant melanoma. Eleven patients were found to have nonmalignant disease (Group 1); 10 were found to have unresectable disease (Group 2); and 12 were rendered disease-free (Group 3). Of the patients found to have melanoma, 20 of 22 received postoperative chemotherapy. The median survival of the patients in Group 2 was 10.5 months (3 to 20 months); in Group 3 it was 12 months (3 to 35 months). There were no 5-year survivors. No factors distinguished the three groups preoperatively. Surgical resection still offers the greatest chance for long-term survival, based on reports of patients in the literature who have survived longer than 5 years following resection of pulmonary metastases from melanoma. Thoracotomy is especially useful for staging purposes in those patients found to have no metastatic disease.




This article has been cited by other articles:


Home page
 J. Thorac. Cardiovasc. Surg.Home page
L. Tafra, P. S. Dale, L. A. Wanek, K. P. Ramming, and D. L. Morton
Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax
J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 119 - 129.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
D. W. O. Moores
Pulmonary metastases revisited
Ann. Thorac. Surg., August 1, 1991; 52(2): 178 - 179.
[PDF]

Home page
 Ann. Thorac. Surg.Home page
L. A. Gorenstein, J. B. Putnam, G. Natarajan, C. A. Balch, and J. A. Roth
Improved survival after resection of pulmonary metastases from malignant melanoma
Ann. Thorac. Surg., August 1, 1991; 52(2): 204 - 210.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
H. W. Pogrebniak, M. Stovroff, J. A. Roth, and H. I. Pass
Resection of Pulmonary Metastases from Malignant Melanoma: Results of a 16-Year Experience
Ann. Thorac. Surg., July 1, 1988; 46(1): 20 - 23.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
T. Aberg, K.-A. Malmberg, B. Nilsson, and E. Nou
The Effect of Metastasectomy: Fact or Fiction?
Ann. Thorac. Surg., October 1, 1980; 30(4): 378 - 384.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1979 by The Society of Thoracic Surgeons.